(ECNS) iShares MSCI China - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46429B2007 • China Region

ECNS: Chinese, Small-Cap, Stocks, Equities

The iShares MSCI China Small-Cap ETF (NYSE ARCA: ECNS) is a U.S.-listed exchange-traded fund designed to provide exposure to the small-capitalization segment of the Chinese equity markets. The fund primarily invests in H-shares and B-shares, which are Chinese companies listed on the Hong Kong and Shanghai/Shenzhen stock exchanges, respectively. By tracking the MSCI China Small Cap Index, the ETF aims to replicate the performance of small-cap Chinese companies, offering investors a targeted way to access this specific market segment. The funds portfolio is constructed using a market capitalization-weighted approach, with a focus on maintaining a minimum of 80% of its assets in securities that align with the underlying index or exhibit substantially similar economic characteristics.

From a technical perspective, ECNS is currently trading above its 20-day, 50-day, and 200-day moving averages, indicating bullish momentum in the near term. The average true range (ATR) of 0.53 suggests relatively stable price movements, with moderate volatility expected in the coming weeks. Based on the current trend, the fund is likely to maintain its upward trajectory in the next three months, supported by strengthening economic fundamentals in China and increased investor appetite for small-cap equities. However, risks such as regulatory changes in China and broader market volatility could impact performance. With assets under management (AUM) of $67.64 million, ECNS remains a niche but focused vehicle for accessing the small-cap segment of the Chinese market.

Additional Sources for ECNS ETF

ECNS ETF Overview

Market Cap in USD 62m
Category China Region
TER 0.59%
IPO / Inception 2010-09-28

ECNS ETF Ratings

Growth Rating -13.3
Fundamental -
Dividend Rating 39.9
Rel. Strength 13.1
Analysts -
Fair Price Momentum 26.92 USD
Fair Price DCF -

ECNS Dividends

Dividend Yield 12m 5.81%
Yield on Cost 5y 5.27%
Annual Growth 5y -2.86%
Payout Consistency 85.7%

ECNS Growth Ratios

Growth Correlation 3m 8.9%
Growth Correlation 12m 64.3%
Growth Correlation 5y -79.2%
CAGR 5y -1.02%
CAGR/Max DD 5y -0.02
Sharpe Ratio 12m 0.12
Alpha 16.67
Beta 0.560
Volatility 35.89%
Current Volume 8.6k
Average Volume 20d 16.6k
What is the price of ECNS stocks?
As of April 25, 2025, the stock is trading at USD 27.51 with a total of 8,590 shares traded.
Over the past week, the price has changed by +7.08%, over one month by -2.20%, over three months by +9.91% and over the past year by +23.87%.
Is iShares MSCI China a good stock to buy?
Neither. Based on ValueRay Analyses, iShares MSCI China is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -13.27 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ECNS as of April 2025 is 26.92. This means that ECNS is currently overvalued and has a potential downside of -2.14%.
Is ECNS a buy, sell or hold?
iShares MSCI China has no consensus analysts rating.
What are the forecast for ECNS stock price target?
According to ValueRays Forecast Model, ECNS iShares MSCI China will be worth about 29.7 in April 2026. The stock is currently trading at 27.51. This means that the stock has a potential upside of +7.82%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 29.7 7.8%